Australians will have access to a single super shot Moderna vaccine for Covid and the flu

Australians will have access to a single vaccine for COVID-19 and flu by 2024 as clinical trials begin.

The combined injection for flu, COVID-19 and respiratory virus RSV is in early testing and trials will begin later this year, said Paul Burton, Moderna’s chief medical officer.

dr. Burton expects combined vaccines to be key to fighting respiratory disease in the wake of the pandemic, and to adapting to multiple strains within a single season.

A single shot for COVID-19 and flu has reached clinical trials with the site of Moderna’s new vaccine manufacturing hub to be announced in a few weeks

The combined injection for flu, COVID-19 and respiratory virus RSV is in early testing and trials will begin later this year

“We still have to be careful, this battle is not over and we can’t be on our guard,” he told Sky News on Monday.

Burton said bringing together and adapting vaccines will be the future, if we think about diseases other than COVID-19.

Meanwhile, Australia’s multi-billion dollar mRNA production hub will be bigger than initially expected.

The first of its kind in the Southern Hemisphere, the facility was announced in March by the Morrison government as part of an agreement with Moderna.

The site finding is in its final stages, and a venue will be announced in a few weeks, said Michael Azrak, Moderna’s general manager.

“It has taken a little longer than we expected as we are going to build a bigger facility than we expected,” he told Sky News.

The pharmaceutical giant aims to break ground on the Victorian site before the end of the year, Azrak said.

It will be operational by the end of 2024, subject to drug regulatory approval.